; (B) recommended information to include as instruction for use to disseminate with at-home disposal systems; and (C) best practices and educational tools to support the use of an at-home disposal system. (3) Updates The Secretary shall update the guidance under this subsection not less frequently than every 5 years. . 204. Report on at-home drug disposal systems Subsection (n) of section 505–1 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1 ), as added by section 5, is amended by adding at the end the following: (4) Report on at-home drug disposal systems (A) In general Not later than one year after the date of enactment of the SUPPORT for Patients and Communities Reauthorization Act of 2023 , the Secretary, in consultation with the Administrator of the Drug Enforcement Administration, shall issue a report outlining steps to improve access to at-home drug disposal systems. (B) Report The report required under subparagraph (A) shall include— (i) a review of commercially available at-home drug disposal systems; (ii) current usage of at-home drug disposal systems; (iii) any barriers to development, including information necessary to independently verify deactivation of appropriate drugs and challenges with real world testing; (iv) any barriers to distribution of at-home drug disposal systems; and (v) best practices for educational resources to inform distribution and use of at-home drug disposal systems. . 205. Ensuring State choice in PDMP systems Section 399O(h) of the Public Health Service Act ( 42 U.S.C. 280g–3(h) ) is amended by adding the following: (5) Ensuring State choice Nothing in this section shall be construed to— (A) direct, require or encourage a State to use a specific interstate data sharing program; (B) limit or prohibit the discretion of a PDMP to utilize interoperability connections of its choice; (C) permit, encourage, or otherwise condition Federal financial assistance to States based upon the use of open architecture by PDMP systems or contracted vendors